Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

- Click on the first letter of the keyword:
  - A
  - B
  - C
  - D
  - E
  - G
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z
  - Other

Search results for: F
Results 61 - 70 of 245 shown below

FcRI

R Repp, H H van Ojik, T Valerius, G Groenewegen, G Wieland, C Oetzel, B Stockmeyer, W Becker, M Eisenhut, H Steininger, Y M Deo, G H Blijham, J R Kalden, J G J van de Winkel and M Gramatzki

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcRI $times$ anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

doi:10.1038/sj.bjc.6601367

Abstract | Full article | PDF
FcR

M Dettke and H Loibner

Different types of FC -receptors are involved in anti-Lewis Y antibody induced effector functions in vitro

doi:10.1054/bjoc.1999.0940

Abstract | Full article | PDF
FcR, lymphoma

L Ottonello, A L Epstein, M Mancini, G Tortolina, P Dapino and F Dallegri

Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fc -receptors

doi:10.1054/bjoc.2001.1940

Abstract | Full article | PDF
FDA

G Apolone, R Joppi, V Bertele' and S Garattini

Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures

advance online publication, 2005-08-23 00:00:00.000;

doi:10.1038/sj.bjc.6602750

Abstract | Full article | PDF
FDG

S Yasuda, M Ide, H Fujii, T Nakahara, Y Mochizuki, W Takahashi and A Shohtsu

Application of positron emission tomography imaging to cancer screening

doi:10.1054/bjoc.2000.1496

Abstract | Full article | PDF
FDG PET

I Sobhani, E Tiret, R Lebtahi, T Aparicio, E Itti, F Montravers, C Vaylet, P Rougier, T André, J M Gornet, D Cherqui, C Delbaldo, Y Panis, J N Talbot, M Meignan and D Le Guludec

Early detection of recurrence by ¹⁸FDG-PET in the follow-up of patients with colorectal cancer

advance online publication, 2008-02-26 00:00:00.000;

doi:10.1038/sj.bjc.6604263

Abstract | Full article | PDF
J Nuutinen, H Minn, J Bergman, M Haaparanta, U Ruotsalainen, H Laine and J Knuuti

Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study

doi:10.1038/sj.bjc.6690386

Abstract | Full article | PDF
FDG-PET

S A Suttie, K G M Park and T A D Smith

[¹⁸F]2-Fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil

advance online publication, 2007-09-11 00:00:00.000;

doi:10.1038/sj.bjc.6603971

Abstract | Full article | PDF
H Shoda, Y Kakugawa, D Saito, T Kozu, T Terauchi, H Daisaki, C Hamashima, Y Muramatsu, N Moriyama and H Saito

Evaluation of ¹⁸F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy

advance online publication, 2007-11-27 00:00:00.000;

doi:10.1038/sj.bjc.6604062

Abstract | Full article | PDF
J Dose-Schwarz, R Tiling, S Avril-Sassen, S Mahner, A Lebeau, C Weber, M Schwaiger, F Jänicke, M Untch and N Avril

Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer

advance online publication, 2009-11-17 00:00:00.000;

doi:10.1038/sj.bjc.6605427

Abstract | Full article | PDF
feasibility

D R Camidge, M N Pemberton, J W Growcott, D Johnstone, P J Laud, J R Foster, K J Randall and A M Hughes

Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development

advance online publication, 2005-07-05 00:00:00.000;

doi:10.1038/sj.bjc.6602686

Abstract | Full article | PDF
feasibility study

M Tsukuda, A Kida, M Fujii, N Kono, T Yoshihara, Y Hasegawa and M Sugita

Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer

advance online publication, 2005-09-27 00:00:00.000;

doi:10.1038/sj.bjc.6602804

Abstract | Full article | PDF
J Cebon

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

advance online publication, 2006-09-05 00:00:00.000;

doi:10.1038/sj.bjc.6603325

Abstract | Full article | PDF
febrile neutropenia

I Ray-Coquard, C Borg, Th Bachelot, C Sebban, I Philip, G Clapisson, A Le Cesne, P Biron, F Chauvin and J Y Blay

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

doi:10.1038/sj.bjc.6600724

Abstract | Full article | PDF
H E Innes, D B Smith, S M O'Reilly, P I Clark, V Kelly and E Marshall

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study

doi:10.1038/sj.bjc.6600993

Abstract | Full article | PDF
H Innes, L Billingham, C Gaunt, N Steven and E Marshall

Management of febrile neutropenia in the United Kingdom: time for a national trial?

doi:10.1038/sj.bjc.6602872

Abstract | Full article | PDF
A Wailoo, A Sutton and A Morgan

The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis

doi:10.1038/sj.bjc.6604863

Abstract | Full article | PDF
S Kelly and D Wheatley

Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors

doi:10.1038/sj.bjc.6605269

Abstract | Full article | PDF
M Cullen and S Baijal

Prevention of febrile neutropenia: use of prophylactic antibiotics

doi:10.1038/sj.bjc.6605270

Abstract | Full article | PDF
P Trueman

Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review

doi:10.1038/sj.bjc.6605271

Abstract | Full article | PDF
D Cameron

Management of chemotherapy-associated febrile neutropenia

doi:10.1038/sj.bjc.6605272

Abstract | Full article | PDF
D Krell and A L Jones

Impact of effective prevention and management of febrile neutropenia

doi:10.1038/sj.bjc.6605273

Abstract | Full article | PDF